The Impact of the Myeloid Response to Radiation Therapy


Radiation therapy is showing potential as a partner for immunotherapies in preclinical cancer models and early clinical studies. As has been discussed elsewhere, radiation provides debulking, antigen and adjuvant release, and inflammatory targeting of effector cells to the treatment site, thereby assisting multiple critical checkpoints in antitumor adaptive immunity. Adaptive immunity is terminated by inflammatory resolution, an active process which ensures that inflammatory damage is repaired and tissue function is restored. We discuss how radiation therapy similarly triggers inflammation followed by repair, the consequences to adaptive immune responses in the treatment site, and how the myeloid response to radiation may impact immunotherapies designed to improve control of residual cancer cells.

DOI: 10.1155/2013/281958

Extracted Key Phrases

1 Figure or Table

Citations per Year

Citation Velocity: 10

Averaging 10 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@inproceedings{Gough2013TheIO, title={The Impact of the Myeloid Response to Radiation Therapy}, author={Michael J. Gough and Kristina H Young and Marka R. Crittenden}, booktitle={Clinical & developmental immunology}, year={2013} }